XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 7,387 $ 4,880
Fixed maturities, current 25,952 26,267
Equity securities 953 1,881
Premium receivables 7,083 5,681
Self-funded receivables 4,663 4,010
Other receivables 4,298 3,749
Other current assets 5,281 4,654
Total current assets 55,617 51,122
Fixed maturity securities, long-term 752 632
Other invested assets, long-term 5,685 5,225
Property and equipment, net 4,316 3,919
Goodwill 24,383 24,228
Total intangible assets 10,315 10,615
Other noncurrent assets 1,704 1,719
Total assets 102,772 97,460
Liabilities and Equity    
Medical claims payable 15,596 13,518
Other policyholder liabilities 5,933 5,521
Unearned income 1,112 1,153
Accounts payable and accrued expenses 5,607 4,970
Short-term borrowings 265 275
Current portion of long-term debt 1,500 1,599
Other current liabilities 9,683 7,849
Total current liabilities 39,696 34,885
Long-term debt, less current portion 22,349 21,157
Reserves for future policy benefits 737 802
Deferred tax liabilities, net 2,034 2,805
Other noncurrent liabilities 1,562 1,683
Total liabilities 66,378 61,332
Commitments and Contingencies—Note 14
Shareholders' equity    
Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none 0 0
Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 237,958,067 and 241,770,746 2 2
Additional paid-in capital 9,084 9,148
Retained earnings 29,724 27,088
Accumulated other comprehensive loss (2,503) (178)
Total shareholders' equity 36,307 36,060
Noncontrolling interests 87 68
Total equity 36,394 36,128
Total liabilities and equity $ 102,772 $ 97,460